Buscar
Mostrando ítems 1-1 de 1
Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)
(BMJ, 2018-01-17)
[Abstract] Objective Evaluate apremilast efficacy across various psoriatic arthritis (PsA) manifestations beginning at week 2 in biological-naïve patients with PsA.
Methods Patients were randomised (1:1) to apremilast ...